Clinical, Neuroimaging, and Pathological Data
Available chart and electronic medical records were reviewed. Presenting signs and symptoms and relevant medical history were identified, with particular attention given to a history of NF, prior radiotherapy, or other tumors. Magnetic resonance imaging studies and reports were also reviewed to establish tumor size/volume, characteristics, and location.
Surgical Approach
Patients were positioned supine and general anesthesia was administered. In most cases, an anterior supraclavicular approach was used. Briefly, a curvilinear incision was made above the clavicle to conform to a skin crease. Sharp dissection was brought down through the skin and the platysma muscle. Depending on the site of the lesion (upper, middle, or lower trunk), the sternocleidomastoid muscle was detached from the clavicular head to facilitate exposure. In some cases, such as with inferior trunk lesions, infraclavicular exposure was required. The supraclavicular fat was dissected, and the omohyoid muscle was retracted. Careful attention was given to isolation and identification of all possible elements of the brachial plexus. Intraoperative stimulation and electromyography were conducted to define plexal anatomy and motor innervation. This allowed identification and sacrifice of nonfunctioning fascicles entering tumors. Once the tumor was identified grossly, the surgical microscope was brought into the field and used to assist in microdissection of the tumor and tumor capsule margins. Successive steps included dissection of adjacent plexus or nonneural elements away from the tumor, identification and opening of the tumor capsule with concurrent intraoperative stimulation, and dissection of tumor away from adjacent nerve fascicles. In cases in which potentially significant motor impairment could result from sacrifice of nerve fascicles by gross-total removal of the tumor, a thin rind of tumor was left to preserve nerve continuity. Thus, the extent of tumor removal varied from extracapsular excision (grosstotal resection), subcapsular gross-total resection, and subtotal resection.
Pathological Examination
In all cases, frozen-section specimens were sent for pathological evaluation. For the purposes of this report, we considered only the final pathological diagnosis. Detailed reports were examined to extract information about tumor size (in cm) and final pathological diagnosis.
RESULTS

Characteristics and Clinical Presentation
In our review we identified 25 patients with primary brachial plexus tumors. Neurofibromatosis was present in eight patients (32%). There was a trend toward younger age in those with NF (40 Ϯ 19 years [mean Ϯ SD]) compared with the patients without this diagnosis (51 Ϯ 12 years) (p = 0.08).
Demographic and clinical characteristics are summarized in Table 1 . Presenting signs and symptoms included the following: mass (60%), paresthesias/numbness (44%), radiating pain (44%), local pain (16%), and weakness (12%). The duration of symptoms ranged from 2 months to 10 years prior to treatment. In one case the lesion was discovered incidentally. Two patients (8%) had previously undergone EBRT, one for breast cancer and one for lymphoma.
Tumor Characteristics
The 25 tumors comprised a heterogeneous group of lesions, both in size and location ( Table 2 ). The smallestvolume lesions were approximately 1 ml in volume and the largest were in excess of 100 ml. Tumors were found along the plexus at all points from the nerve roots and neural foramina through the distal plexus and proximal exiting nerves.
Intraoperative and Pathological Findings
Of 25 tumors, there were 15 schwannomas (60%) (Fig.  1A ), five neurofibromas (20%) (Fig. 1B) , four MPNSTs (16%), (Fig. 1C) , and one desmoid tumor (4%) (Fig. 1D ). All five neurofibromas and one of four MPNSTs were associated with a history of NF. Gross-total resection was achieved in all cases with schwannomas and in one of the five with neurofibromas. One intraoperative complication occurred: avulsion of an artery supplying the tumor from the right subclavian artery during tumor mobilization, but was successfully repaired without clinical sequelae.
DISCUSSION
Epidemiology and Presenting Symptoms
The mean age at diagnosis (47 years) in our series was higher than that in most series. The authors of a Mayo Clinic series of 120 MPNSTs reported a mean patient age of 35 years. 14 In the most recent LSUHSC series, investigators reported a mean age of 25 years in cases involving neurofibromas associated with NF, 42 years in those with non-NF-associated neurofibromas, 42 years in those with schwannomas, and 44 years in cases involving MPNSTs. 20 Interestingly, we observed a sex predilection, with 18 women and seven men in our series, which has been noted in some but not all other series. Of 120 patients in the Mayo series involving patients with MPNSTs, 52 were men and 68 were women. 14 In the Memorial SloanKettering series of 303 patients, 57% were women and 43% were men. 10 In the recent LSUHSC series of 107 patients, however, 49% were men and 51% were women. 20 Patients with peripheral nerve tumors usually present with pain and paresthesias or with a palpable mass. 11, 20, 25, 29 In our series, the most common presenting symptoms were palpable mass, numbness/paresthesias, pain, and weakness, symptomatology in agreement with that in the LSUHSC series. 20, 29 Most often, early in the course, minimal neurological deficit will be present or there will be none at all. Manipulation of the mass can produce paresthesias or "shocks" in the distribution of the affected nerve, and this can be an important aid to diagnosis. Sideto-side greater than longitudinal mobility of the mass from the nerve is more common in cases of benign lesions, whereas malignancy is associated with firmness and immobility.
20,26
Radiological and Neuroimaging Findings
In cases of brachial plexus lesions, MR imaging is the study of choice to delineate the margins of the tumor from surrounding tissues with greatest contrast. 22 Importantly, however, MR imaging is currently unable to differentiate between schwannoma and neurofibroma. 5 Other imaging modalities may be useful in selected cases. Plain radiography can demonstrate apical pulmonary lesions potentially involving the brachial plexus. Computerized tomography scanning is optimal at revealing osseous erosion around the spine or changes in neural foramina. A newer modality, MR neurography, has the potential to demonstrate the entire course of visualized peripheral nerves.
17,18
Pathological Features
It has been well established that the most common primary nerve tumors arise from the neural sheath. These include benign nerve sheath tumors, schwannomas, and neurofibromas. 4, 15 In our series, schwannomas and neurofibromas together accounted for 20 (80%) of 25 tumors.
Other benign tumors can arise from nerves but not nerve sheaths, including desmoids, ganglions, cysts, epidermoids, and lipomas. 20, 29 Of the 20 nonneural brachial plexus lesions reported in the two LSUHSC series, 20, 29 there were seven desmoids, three lipomas, three myositis ossificans, and one each of localized hypertrophic neuropathy, myoblastoma, cavernous angioma, hemangioma, lymphangioma, ganglioneuroma, and brachial cleft cyst. In our series, we observed a single desmoid tumor (Table  2 , Case 8, Fig. 1D ). Desmoid tumors are composed of infiltrative mesenchymal tissue, can encase and invade nerves and blood vessels, and are thus difficult to resect completely. 6, 26 Another nonneoplastic lesion that may rarely involve the brachial plexus is the neuromuscular hamartoma ("triton") tumor. 2 Nonneoplastic lesions, especially hypertrophic neuropathy, may simulate neoplasms of the brachial plexus. Most commonly, interstitial hypertrophic neuropathy manifests as a sensorimotor polyneuropathy, and symptoms are usually bilateral with other associated neurological findings; however, several cases have been described in which patients presented with focal lesions 20, 23, 32, 33 including tumorlike infiltration of the brachial plexus. 33 This condition may lead to thickening of peripheral nerves; evaluation of biopsy specimens demonstrates onion-bulb formation. 33 Also termed neurogenic sarcoma and neurofibrosarcoma, MPNSTs are thought to be of neural origin. 4, 15 Other nonneural malignant tumors, such as soft-tissue sarcomas, can involve nerves by direct extension or metastasis. Although a small number of cases of MPNSTs have been reported in patients without NF, 7, 31 it has long been recognized that NF (especially NF Type 1, von Recklinghausen disease) is associated with a high incidence of MPNST. In 1931, Hosoi 24 calculated that MPNST develops in approximately 13% of patients with von Recklinghausen disease.
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Primary brachial plexus tumor 3 Based on longer-term observation of a large series of patients, Brasfield and Das Gupta 3 reported an overall incidence of 29%. In our series, one of four patients with MPNSTs also had NF.
Interestingly, three of our four patients with MPNSTs did not have NF; two of these patients had previously undergone radiotherapy, one for breast carcinoma and one for lymphoma. These lesions are probably best considered as postirradiation sarcomas. Indeed, the Mayo Clinic series of 120 consecutive MPNSTs included 13 cases of postirradiation sarcomas. 14 In that study, the latency period (duration between radiotherapy and tumor diagnosis) was 17 years (range 5-29 years). Other authors have also reported the appearance of MPNSTs at sites previously irradiated. 13, 16, 19, 30 In addition, the fact that radiation can induce brachial plexopathy can potentially create a diagnostic dilemma. 27 Other than two patients having undergone radiotherapy, there was nothing in the clinical presentation of these cases to aid in the prediction that a malignant tumor was present. In cases of NF, the presence of an enlarging mass or new pain may indicate the need for aggressive resection; however, several patients in this series presented with pain and/or an enlarging mass and harbored benign lesions. Thus, the presence of a new mass in the supraclavicular region should lead to recommendation for surgical exploration.
Procedure-Related Complications
Serious complications due to brachial plexus operations are infrequent. The primary risk is of neurological dysfunction caused by interruption of critical motor branches to arm and hand. In addition, however, plexus tumors can adhere to major vessels. In our series, there was one complication of vascular injury to the right subclavian artery during tumor mobilization (Case 6). Similarly, Ganju, et al., 20 reported two cases of vascular injury during tumor removal.
CONCLUSIONS
We have reported the findings in 25 consecutive cases involving primary brachial plexus tumors (15 schwannomas, five neurofibromas, four MPNSTs, and one desmoid) seen at UCSF over a 10-year period. Clinical presentation most commonly included palpable mass, pain, numbness, or paresthesias. Gross-total removal was possible in all cases of schwannomas, whereas the other lesions 
